Dr. Beck Brachman is a pioneering scientist and social entrepreneur at the forefront of preventative psychopharmacology. Her groundbreaking work focuses on developing drugs, known as alexigents, to enhance psychological resilience against stress and prevent mental illnesses like PTSD and depression. Dr. Brachman's research emphasizes the active biological processes involved in stress resilience and advocates for treatments that address the root causes of psychiatric disorders. Additionally, she is dedicated to revolutionizing the treatment and perception of psychiatric diseases by leveraging the immune system to prevent, treat, and diagnose such conditions. Through her innovative approach, Dr. Brachman is not only reshaping the field of mental health but also contributing to the advancement of social finance models that incentivize impactful social good through market mechanisms.
Areas of Expertise
Biotech, Entrepreneurship, Immunology, Mental health, Neuroscience, Preventing depression and PTSD, Research, Science
